BIND Therapeutics   Report issue

For profit Phase 2
Founded: Cambridge Massachusetts United States (2007)
Status: Acquired by Pfizer (2016)

Organization Overview

First Clinical Trial
2011
NCT01300533
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree